This post was originally published on this site Therapy candidate INB03, meant to inactivate a kind immunosuppressive cell called myeloid-derived suppressor cells (MDSCs) while boosting anti-tumor immune cells, may help overcome resistance to immunotherapies, including immune checkpoint inhibitors, INmune Bio’s co-founder Raymond J. Tesi, MD, said at a conference. Tesi, CEO of INmune Bio, presented the potentialities…
This post was originally published on this site I met a guy at a party. At first, he was quite the charmer, one of those middle-aged guys who was the most popular guy in high school. Standing within his orbit, I felt like I’d been invited to join the cool kids’ cafeteria table and everyone…
This post was originally published on this site Targazyme has been granted an award from the The Sexual Medicine Society of North America that will fund a clinical trial testing the company’s stem cell-based product TZ101 to reverse erectile dysfunction in prostate cancer patients. The study will be conducted at The University of Texas Health…
This post was originally published on this site The U.S. Food and Drug Administration is delaying its decision on a new drug application (NDA) seeking approval of selinexor in combination with dexamethasone for patients with multiple myeloma who failed at least three prior therapies. This means that the FDA will decide whether to approve the oral…
This post was originally published on this site A qualitative study has proposed nine recommendations from breast cancer survivors about how to reduce the financial burden associated with the disease, which include changes to insurance, supportive services, financial assistance, and protective policies. The findings of the study, “Patient recommendations for reducing long‐lasting economic burden after…
This post was originally published on this site Preliminary data from a Phase 2 study suggests that treating early Alzheimer’s disease patients who are positive for herpes simplex virus with an antiviral medicine may help halt their cognitive decline. Hugo Lövheim, MD, PhD, at Umeå University, Sweden, presented the results in a presentation titled “Valz…
This post was originally published on this site Hi Hi test Hi testing doing Hi testing what you hi testing what you are hi testing what you are looking for hi testing what you are looking for why hi testing what you are looking for why not hi testing what you are looking for why…
This post was originally published on this site A new Prostate Cancer Foundation (PCF) collaboration with CURE Media Group, a multimedia platform, is expected to raise awareness of prostate cancer and enhance the scope and availability of disease information. Specifically, the PCF has joined CURE Media’s Strategic Alliance Partnership (SAP) program, which works to cultivate information-sharing…
This post was originally published on this site Novocure has initiated a Phase 3 trial investigating its Tumor Treating Fields (TTFields) — a method that uses electric fields to disrupt cell division — in combination with Taxol (paclitaxel) as a treatment for ovarian cancer patients who are resistant to platinum-based chemotherapy. The trial — which…
This post was originally published on this site An application has been submitted seeking U.S. approval of Darzalex (daratumumab) in combination with standard pre-transplant therapy to treat newly diagnosed multiple myeloma patients who are eligible for a stem cell transplant. Janssen‘s supplemental Biologics License Application to the U.S. Food and Drug Administration (FDA) is for a combination of…
